KLK3 and posterior cortical atrophy: However, the low specificity of the PSA testing for screening PCa and its limitation in detecting clinically significant PCa urge scientists to develop more specific biomarkers to diagnose clinically significant PCa early while avoiding unnecessary biopsies [18].